ARTICLE | Company News
Innate Pharma management update
October 7, 2013 7:00 AM UTC
Innate Pharma S.A. (Euronext:IPH), Marseille, France Business: Cancer, Infectious, Inflammation Hired: Nicolai Wagtmann as CSO, formerly VP of R&D at Novo Nordisk A/S; he succeeds Francois Romagne ...